RBL2 and gastric cancer: Other studies reported that SMAD3 functioned as a tumor suppressor in cancers of the stomach, 39, breast 40 and prostate 41, while RBL2 functions as a tumor suppressor in cancers of the breasts, ovaries and endometrium 42.